About CSL Limited (CSL)
CSL Limited is a Biotechnology company operating in the Healthcare sector. The company is headquartered in Melbourne, Australia. CSL has been publicly traded since 1994, giving it 32+ years of trading history.
CSL Limited (CSL) has been publicly traded since 1994, making it a 32-year-old public company. It operates in the Biotechnology industry within the Healthcare sector. The company is headquartered in Melbourne, Australia and employs approximately 29,904 people. With a market capitalization of A$68 billion, CSL is a large established company.
CSL trades on the Australian Securities Exchange and is classified as a large-cap-cap stock with a market capitalization of approximately A$68 billion. The company employs approximately 29,904 people worldwide.
Key Statistics
- Current Price
- A$141.03
- Market Cap
- A$68.42B
- 52-Week High
- A$275.79
- 52-Week Low
- A$139.22
- Sector
- Healthcare
- Industry
- Biotechnology
CSL Investment Performance
CSL has declined 17.3% year-to-date in 2026. Over the past 5 years, a A$1,000 investment in CSL would have grown to A$574, representing a -42.5% total return. Since its IPO in 1994, a A$1,000 investment would now be worth A$292,539.
A$1,000 Invested in CSL Limited (CSL)
How much would A$1,000 invested in CSL be worth today?
What would A$1,000 invested in CSL 1 year ago be worth today?
A A$1,000 investment in CSL Limited (CSL) in 2025 would be worth A$580 as of March 2026, representing a -42.0% total return.
What would A$1,000 invested in CSL 3 years ago be worth today?
A A$1,000 investment in CSL Limited (CSL) in 2023 would be worth A$516 as of March 2026, representing a -48.4% total return.
What would A$1,000 invested in CSL 5 years ago be worth today?
A A$1,000 investment in CSL Limited (CSL) in 2021 would be worth A$574 as of March 2026, representing a -42.5% total return.
What would A$1,000 invested in CSL 10 years ago be worth today?
A A$1,000 investment in CSL Limited (CSL) in 2016 would be worth A$1,594 as of March 2026, representing a +59.4% total return.
What would A$1,000 invested in CSL at IPO be worth today?
A A$1,000 investment in CSL Limited (CSL) at IPO would be worth A$292,539 as of March 2026, representing a +29153.9% total return.
Monthly Returns Heatmap
Over the past 31+ years (382 months), CSL Limited (CSL) has averaged a monthly return of +1.78% with a median return of +1.89%. The stock had 228 positive months (60%) and 153 negative months (40%). The best month in CSL's history was August 1999 with a +42.3% return, while the worst was May 2003 at -23.8%. Historically, August tends to be the strongest month (averaging +3.5%), and May the weakest (0.4%).
CSL's longest winning streak was 13 consecutive months of gains, while its longest losing streak was 10 consecutive months of losses. The best full year was 2000 with a cumulative return of +67.1%, and the worst was 2002 at -76.5%.
Annual Returns
Over 32 years of trading history, CSL Limited (CSL) has delivered an average annual return of +25.02% with a median return of +28.98%. The compound annual growth rate (CAGR) is +19.43%. The stock posted gains in 23 years (72%) and losses in 9 years (28%).
CSL's best year was 2000 with a +79.86% gain, while the worst was 2002 at -57.52%. The longest streak of consecutive positive years was 7, and the longest losing streak was 3 years. CSL achieved double-digit gains (10%+) in 19 years. It suffered double-digit losses in 4 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -17.26% | A$170.45 | A$141.03 |
| 2025 | -37.47% | A$272.61 | A$170.45 |
| 2024 | -0.43% | A$273.80 | A$272.61 |
| 2023 | +0.91% | A$271.33 | A$273.80 |
| 2022 | +0.13% | A$270.99 | A$271.33 |
| 2021 | +3.72% | A$261.27 | A$270.99 |
| 2020 | +3.72% | A$251.89 | A$261.27 |
| 2019 | +50.75% | A$167.09 | A$251.89 |
| 2018 | +32.64% | A$125.97 | A$167.09 |
| 2017 | +42.66% | A$88.30 | A$125.97 |
| 2016 | -3.02% | A$91.06 | A$88.30 |
| 2015 | +23.71% | A$73.60 | A$91.06 |
| 2014 | +27.86% | A$57.56 | A$73.60 |
| 2013 | +30.10% | A$44.25 | A$57.56 |
| 2012 | +72.12% | A$25.71 | A$44.25 |
| 2011 | -9.44% | A$28.39 | A$25.71 |
| 2010 | +14.38% | A$24.82 | A$28.39 |
| 2009 | -1.61% | A$25.22 | A$24.82 |
| 2008 | -6.14% | A$26.88 | A$25.22 |
| 2007 | +68.81% | A$15.92 | A$26.88 |
| 2006 | +55.88% | A$10.21 | A$15.92 |
| 2005 | +47.73% | A$6.91 | A$10.21 |
| 2004 | +66.28% | A$4.16 | A$6.91 |
| 2003 | -15.65% | A$4.93 | A$4.16 |
| 2002 | -57.52% | A$11.60 | A$4.93 |
| 2001 | +32.65% | A$8.75 | A$11.60 |
| 2000 | +79.86% | A$4.86 | A$8.75 |
| 1999 | +58.62% | A$3.07 | A$4.86 |
| 1998 | +48.33% | A$2.07 | A$3.07 |
| 1997 | +64.57% | A$1.26 | A$2.07 |
| 1996 | +52.32% | A$0.82 | A$1.26 |
| 1995 | +71.40% | A$0.48 | A$0.82 |
CSL Investment Analysis: Valuation, Risk & Dividends
Key factors to consider when evaluating CSL Limited as an investment
Valuation
CSL currently trades at a trailing P/E ratio of 16.3, which is considered moderate relative to the broader market. The forward P/E of 13.3 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 2.5. The price-to-sales ratio is 4.4.
Dividends
CSL Limited pays a dividend to shareholders with a current yield of 3.02%. This translates to A$4.26 per share annually. The payout ratio of 45% indicates sustainable dividend coverage.
Risk & Volatility
CSL has a beta of 0.21, indicating it is less volatile than the overall market. The stock's 52-week range is A$139.22 to A$275.79, and it currently trades near its 52-week low.
Analyst Ratings
Based on 16 analyst opinions, CSL has a consensus "buy" rating. The average price target of A$208.96 suggests 48.2% upside from current levels.
Frequently Asked Questions: CSL
What sector is CSL in? ▼
CSL operates in the Healthcare sector, specifically in the Biotechnology industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has CSL performed historically? ▼
Over 32 years of trading history, CSL has posted gains in 23 years (72% of the time). The best year was 2000 with a +79.9% return. Past performance does not guarantee future results.
How can I invest in CSL? ▼
You can invest in CSL through any brokerage account that offers access to the Australian Securities Exchange. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold CSL.
Does CSL pay dividends? ▼
CSL Limited pays a dividend to shareholders with a current yield of 3.02%. This translates to A$4.26 per share annually. The payout ratio of 45% indicates sustainable dividend coverage.
What does CSL Limited do? ▼
CSL Limited is a Biotechnology company operating in the Healthcare sector. The company is headquartered in Melbourne, Australia.
What sector is CSL in? ▼
CSL operates in the Healthcare sector, specifically in the Biotechnology industry.
When did CSL go public? ▼
CSL Limited went public in 1994, making it a 32-year-old public company as of 2026.
How much would A$1,000 invested in CSL 5 years ago be worth today? ▼
A A$1,000 investment in CSL five years ago would be worth approximately A$574 today, representing a -42.5% return.
How much would A$1,000 invested in CSL 10 years ago be worth today? ▼
A A$1,000 investment in CSL ten years ago would be worth approximately A$1,594 today, representing a 59.4% total return over the decade.
What is CSL's 3-year return? ▼
Over the past 3 years, CSL has returned -48.4%. A A$1,000 investment would have grown to A$516.
How much would A$1,000 invested in CSL at IPO be worth today? ▼
If you invested A$1,000 in CSL at its IPO in 1994, it would be worth approximately A$292,539 today, a 29,153.9% return over 32 years.
Does CSL pay dividends? ▼
Yes, CSL Limited pays a dividend with a current yield of 3.02%, which is A$4.26 per share annually.
What is CSL's market cap? ▼
CSL Limited has a market capitalization of A$68 billion, classifying it as a large-cap company.
What is CSL's P/E ratio? ▼
CSL has a trailing P/E ratio of 16.3 and a forward P/E of 13.3, which measures how much investors are paying per dollar of earnings.
Is CSL a buy, hold, or sell? ▼
Based on 16 opinions, CSL has a consensus "buy" rating. The average price target is A$208.96.
Last updated: 3/15/2026